About Us

Pharmalicensing - Partnering solutions for the life sciences

 

Our Products

Overview

Partnering Search

Company Profiling

Deal Negotiation

PL Intelligence

Reports

Comparison

 

PL Intelligence

Overview

Industry news

Deals review

Press releases

Articles

 

Case Studies

See what others think about our service

 

Newsletter

Partnering update

Key reports

Subscribe

 

Quick Links

Profile now

Register now

Profiled companies

Featured events

Industry news

PR Newswire

Jobs

 

Contact Pharmalicensing

Send an email

Call us: +44 1904 520460

Request a callback

 

RSS Feeds

Keep up to date

Novartis launches Prevacid

Covidien Introduces First FDA-Approved Spine Sealant

The European Commission grants Orphan Drug designation for NGR-hTNF in the treatment of hepatocellular carcinoma

Kensey Nash Receives FDA 510(k) Clearance for Porcine Dermis Biologic Product

Pandemic 2009 Influenza Update: US FDA approves GSK's pandemic H1N1 vaccine

IRONWOOD AND ASTELLAS ANNOUNCE JAPAN LICENSING AGREEMENT FOR LINACLOTIDE

Merit Medical Announces 510(K) Clearance for the Merit Laureate(TM) Hydrophilic Guide Wire

Lonza successfully develops a manufacturing process for ArzerraTM (ofatumumab), a new biopharmaceutical from GSK and Genmab

Teva Receives Favorable Court Decision Regarding Generic Prevacid

Teva Receives Final Approval For Generic Prevacid

Clients in focus...